Neurobiological Technologies' IPO

Neurobiological Technologies raised a round of funding on October 12, 2004. Investors include Public.

Neurobiological Technologies, Inc. (NTI) (Nasdaq: NTII) is an emerging drug development company focused on the clinical development and regulatory approval of neuroscience drugs. The company is involv…

Articles about Neurobiological Technologies' IPO: